ZOLADEX is a Subcutaneous Implant in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Goserelin Acetate.
| Product ID | 50090-3466_85bc1c89-64e7-49f1-ad4e-a7c634dbf0da |
| NDC | 50090-3466 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ZOLADEX |
| Generic Name | Goserelin Acetate |
| Dosage Form | Implant |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2018-03-31 |
| Marketing Category | NDA / NDA |
| Application Number | NDA019726 |
| Labeler Name | A-S Medication Solutions |
| Substance Name | GOSERELIN ACETATE |
| Active Ingredient Strength | 4 mg/1 |
| Pharm Classes | Gonadotropin Releasing Hormone Receptor Agonist [EPC],Gonadotropin Releasing Hormone Receptor Agonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2018-05-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA019726 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-05-30 |
| Ingredient | Strength |
|---|---|
| GOSERELIN ACETATE | 3.6 mg/1 |
| SPL SET ID: | a906a5bd-d2ec-4e35-8962-c0c86c637630 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0310-0950 | ZOLADEX | Goserelin acetate |
| 0310-0951 | ZOLADEX | Goserelin acetate |
| 50090-2027 | ZOLADEX | Goserelin acetate |
| 50090-3466 | ZOLADEX | goserelin acetate |
| 70720-950 | ZOLADEX | goserelin acetate |
| 70720-951 | ZOLADEX | goserelin acetate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ZOLADEX 74588633 1938346 Dead/Cancelled |
Zeneca Limited 1994-10-21 |
![]() ZOLADEX 74324147 1885525 Dead/Cancelled |
Zeneca Limited 1992-10-21 |
![]() ZOLADEX 74010646 1624402 Live/Registered |
IMPERIAL CHEMICAL INDUSTRIES PLC 1989-12-14 |
![]() ZOLADEX 73545833 1402790 Live/Registered |
IMPERIAL CHEMICAL INDUSTRIES PLC 1985-07-01 |